Evaluation of patients with Crimean-Congo hemorrhagic fever in Bolu, Turkey

African Health Sciences

Volumn 13, Issue 2, 2013, Pages 233-242

  Duran, Arif ^a   Kucukbayrak A ^a   Ocak, T ^a   Hakyemez, N I ^a   Tath, T ^a   Karadad, M ^b   Mengelodlu, Z F ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b NONE

Author keywords

Black Sea; Crimean Congo hemorrhagic fever virus

Indexed keywords

CREATINE KINASE; LACTATE DEHYDROGENASE;

AGED; AGRICULTURAL WORKER; ANIMAL HUSBANDRY; ARTICLE; CAUSE OF DEATH; CHILD; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; CRIMEAN CONGO HEMORRHAGIC FEVER; DISEASE ASSOCIATION; FATIGUE; FEMALE; FEVER; GEOGRAPHIC DISTRIBUTION; HEADACHE; HEALTH CARE PERSONNEL; HOUSEWIFE; HUMAN; INFANT; LEUKOPENIA; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; MYALGIA; NAUSEA; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT CODING; PHYSICAL EXAMINATION; PRESCHOOL CHILD; RISK ASSESSMENT; RISK FACTOR; THROMBOCYTOPENIA; TICK BITE; TURKEY (REPUBLIC);

BLACK SEA; CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS;

ADOLESCENT; ADULT; AGED; BLACK SEA; CHILD; CHILD, PRESCHOOL; FEMALE; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; INFANT; MALE; MIDDLE AGED; TURKEY; YOUNG ADULT;

EID: 84883715809     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: 10.4314/ahs.v13i2.5     Document Type: Article

References (45)

1. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 1989; 11:794-800.
2. Chris A. Whitehouse. Crimean-Congo hemorrhagic fever. Antiviral Research. 2004; 64(3): 145-60
3. Khan AS, Maupin GO, Rollin PE, Noor AM, Shurie HH, Shalabi AG, et all. An outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates. Am J Trop Med Hyg 1997;57:519-25.
4. Papa A, Christova I, Papadimitriou E, Antoniadis A. Crimean-Congo hemorrhagic fever in Bulgaria. Emerg Infect Dis 2004; 10: 1465-67.
5. Alavi-Naini R, Moghtaderi A, Koohpayeh HR, Sharifi-Mood B, Naderi M, Metanat M, et all. Crimean-Congo hemorrhagic fever in Southeast of Iran. J Infect 2006;52:378-82.
6. S. K. Al-Tikriti, F. Al-Ani, F. J. Jurji, H. Tantawi, M. Al-Moslih, N. Al-Janabi, et all. Congo/ Crimean haemorrhagic fever in Iraq. Bull World Health Organ 1981;59:85-90.
7. Gunes T, Engin A, Poyraz O, Elaldi N, Kaya S, Dokmetas I, et all. Crimean-Congo hemorrhagic fever virus in high-risk population, Turkey. Emerg Infect Dis. 2009; 15(3): 461-64.
8. Ergonul O, Zeller H, Celikbas A, Dokuzoguz B. The lack of Crimean-Congo hemorrhagic fever virus antibodies in healthcare workers in an endemic region. Int J Infect Dis 2007; 11:48-51.
9. http://www.bolu.gov.tr/documents/ genel_bilgiler.pdf29
10. Sharifi Mood B, Alavi-naini R, Metanat M. Ten years after the beginning of Crimean-Congo hemorrhagic fever outbreak in Iran: A promising report. Iran J Clin Infect Dis. 2009;4:189-93
11. Azeem S. Sheikha, Aqleem A. Sheikhb, Nadeem S. Sheikhc, Rafi-U-Shand, Mohammad Asife, Farhan Afridie, et all. Bi-annual surge of Crimean-Congo haemorrhagic fever (CCHF): A five-year experience. Int J Infect Dis. 2005;9:37-42
12. Ergonul O, Celikbas A, Dokuzoguz B, Eren S, Baykam N, Esener H. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in turkey and impact of oral ribavirin therapy. Clin Infect Dis. 2004;39:284-87
13. Karti SS, Odabasi Z, Korten V, Yilmaz M, Sonmez M, Caylan R, et all. Ksiazek. Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis. 2004;10:1379-84
14. Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran MA, Vahaboglu H. Crimean-Congo haemorrhagic lever outbreak in Middle Anatolia: A multicentre study of clinical features and outcome measures. J Med Microbiol. 2005;54:385-89
15. Yilmaz GR, Buzgan T, Irmak H, Safran A, Uzun R, Cevik MA, et all. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002-2007. Int J Infect Dis. 2009;13(3):380-86
16. Ozkurt Z, Kiki I, Erol S, Erdem F, Yýlmaz N, Parlak M, et all. Tasyaran Crimean-Congo hemorrhagic fever in Eastern Turkey: Clinical features, risk factors and efficacy of ribavirin therapy. J Infect. 2006;52:207-15
17. Vorou R, Pierroutsakos IN, Maltezou HC. Crimean-Congo hemorrhagic fever. Curr Opin Infect Dis 2007;20:495-500.
18. Cevik MA, Uzun R, Yilmaz N, Ugurlu M, Elaldi N, Bodur H, et all. Risk factors for Crimean-Congo haemorrhagic fever outbreak in Central Anatolia: a case control study. R2227. 15th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). 2005.
19. Swanepoel R, Shepherd AJ, Leman PA, Shepherd SP, Miller GB. A common-source outbreak of Crimean-Congo haemorrhagic fever on a dairy farm. S Afr Med J 1985;68:635-37.
20. Izadi S, Holakouie-Naieni K, Majdzadeh SR, Chinikar S, Nadim A, Rakhshani F, et all. Seroprevalence of Crimean-Congo hemorrhagic fever in Sistan-va-Baluchestan Province of Iran. Jpn J Infect Dis 2006;59:326-28.
21. Yilmaz GR, Buzgan T, Irmak H, Safran A, Uzun R, Cevik MA, et al. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002-2007. Int J Infect Dis. 2009;13(3):380-86.
22. Watts DM, Ksiazeck TG, Linthicum KJ, Hoogstraal H. Crimean-Congo hemorrhagic fever. In: Monath TP, editor. The Arboviruses: Epidemiology and Ecology. Florida: CRC Press; 1988:177-222
23. Whitehouse CA. Crimean-Congo hemorrhagic fever. Antivir Res 2004;64:145-60.
24. Schwarz TF, Nsanze A, Ameen AM. Clinical features of Crimean-Congo haemorrhagic fever in the United Arab Emirates. Infection 1997;40:364-67.
25. Hoogstraal H. The epidemiology of tick-borne Crimean-Congo haemorrhagic fever in Asia, Europe and Africa. J Med Entomol 1979;15:307-417
26. Suma B. An Update on Crimean Congo Hemorrhagic Fever. J Glob Infect Dis. 2011; 3(3): 285-92.
27. David R. Franz, Peter B. Jahrling, Arthur M. Friedlander, David J. McClain, David L. Hoover, W. Russell Bryne, et all. Clinical recognition and management of patients exposed to biological warfare agents. JAMA. 1997;278:399-411
28. Ergönül O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 2006;6:203-14
29. Hoogstraal H. The epidemiology of tick borne Crimean-Congo hemorrhagic fever in Asia, Europe and Africa. J Med Entomol. 1979;15:307-417
30. Sannikova IV, Pacechnikov VD, Maleev VV. Respiratory lesions in Crimean-Congo hemorrhagic fever. Ter Arkh. 2007;79:20-23.
31. Doganci L, Ceyhan M, Tasdeler NF, Sarikayalar H, Tulek N. Crimean-Congo hemorrhagic fever and diffuse alveolar haemorrhage. Trop Doct. 2008;38:252-54
32. Alavi-Naini R, Moghtaderi A, Koohpayeh HR, Sharifi-Mood B, Naderi M, Metanat M, et all. Crimean-Congo hemorrhagic fever in Southeast of Iran. J Infect 2006;52:378-82
33. Peters CJ, Bunyaviridae. California encephalitis. Hantavirus pulmonary syndrome andbunyavirid hemorrhagic fevers. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 6th ed. Philadelphia: Churchill Livingstone; 2005. p. 2086-90.33
34. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 1989;11(Suppl 4):S794-800.
35. Dowall SD, Richards KS, Graham VA, Chamberlain J, Hewson R. Development of an indirect ELISA method for the parallel measurement of IgG and IgM antibodies against Crimean-Congo haemorrhagic fever (CCHF) virus using recombinant nucleoprotein as antigen. J Virol Methods. 2012;179:335-41
36. Shepherd AJ, Swanepoel R, Leman PA. Antibody response in Crimean-Congo hemorrhagic fever. Rev Infect Dis. 1989;11 Suppl 4:S801-06.
37. Bossi P, Van Loock F, Tegnell A, Gouvras G; Task Force on Biological andChemical Agent Threats, Public Health Directorate, European Commission, Luxembourg. Bichat clinical guidelines for bioterrorist agents. Euro Surveill. 2004;9(12):E1-2.
38. Borio L, Inglesby T, Peters CJ, Schmaljohn AL, Hughes JM, Jahrling PB, et all. Working Group on Civilian Biodefense. Hemorrhagic fever viruses as biological weapons: medical and public healthmanagement. JAMA. 2002;287(18):2391-405.
39. World Health Organization. Crimean-Congo haemorrhagic fever. Fact sheet 208. Geneva: World Health Organization; 2001. Available at: http://www.who.int/mediacentre/factsheets/ fs208/en/.(accessed May 2009)
40. Centers for Disease Control and Prevention (CDC). Update: management of patients with suspected viral hemorrhagic fever-United States. MMWR Morb Mortal Wkly Rep 1995; 44:475-79.
41. Smego Jr RA, Sarwari AR, Siddiqui AR. Crimean-Congo hemorrhagic fever: prevention and control limitations in a resourcepoor country. Clin Infect Dis 2004;38:1731-35
42. Ascioglu S, Elaldi N, Bodur H, Vahaboglu H, Leblebicioglu H. Response to Doganci J Infect 2009;59: 290-91
43. Koksal Ý, Yilmaz G, Aksoy F, Aydin H, Yavuz Ý, Iskender S, et all. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey. J Clin Virol 2010;47:65-68
44. Ascioglu S, Leblebicioglu H, Vahaboglu H, Chan KA. J Antimicrob Chemoher 2011;66:1215-22
45. Kandis H, Katirci Y, Baltaci D, Saritas A, Kara IH, Geyik MF. Investigation of Clinical and Laboratory Findings of 26 Cases with Crimean-Congo Hemorrhagic Fever. Biomedical Research, 2012; 23 (4): 589-95